EXOMIND (BTL-995) for Reduction of Binge-eating
NCT06910592
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Binge-Eating Disorder
Interventions
DEVICE:
Treatment with BTL-995-rTMS
Sponsor
BTL Industries Ltd.